Correspondence 0001104659-25-013977 from Vyome Holdings, Inc (HIND)
Vyome Holdings, Inc
Date: Feb. 14, 2025 · CIK: 0001427570 · Accession: 0001104659-25-013977
AI Filing Summary & Sentiment
File numbers found in text: 333-284362
Letter
Re: ReShape Lifesciences Inc.
February 14, 2025
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Registration Statement on Form S-1
File No. 333-284362
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations of the U.S. Securities and Exchange Commission under the Securities Act of 1933, as amended, Maxim Group LLC (“Maxim”), as placement agent, hereby concurs in the request by ReShape Lifesciences Inc. that the effective date of the above-referenced Registration Statement be accelerated to 4:00 PM, Eastern Time, on Friday, February 14, 2025, or as soon thereafter as may be practicable.
Maxim affirms that it is aware of its obligations under the Securities Act in connection with this offering.
Very truly yours,
Maxim Group LLC
Show Raw Text
CORRESP
1
filename1.htm
February 14, 2025
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re:
ReShape Lifesciences Inc.
Registration Statement on Form S-1
File No. 333-284362
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and
Regulations of the U.S. Securities and Exchange Commission under the Securities Act of 1933, as amended, Maxim Group LLC (“Maxim”),
as placement agent, hereby concurs in the request by ReShape Lifesciences Inc. that the effective date of the above-referenced Registration
Statement be accelerated to 4:00 PM, Eastern Time, on Friday, February 14, 2025, or as soon thereafter as may be practicable.
Maxim affirms that it is aware
of its obligations under the Securities Act in connection with this offering.
Very truly yours,
Maxim Group LLC
By:
/s/ Ritesh
Veera
Name: Ritesh Veera
Title: Co-Head of Investment Banking